Latest ROE for Future Health ESG - Warrants (09/09/2026): 22.89% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow22.89%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Future Health ESG - Warrants (09/09/2026)'s return on equity stands at 22.89%. That is above the sector sector average of 11.64%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Future Health ESG - Warrants (09/09/2026) sits higher the its sector benchmark (11.64%) with a ROE of 22.89%. That is roughly 96.7% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 22.89% for Future Health ESG - Warrants (09/09/2026) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Future Health ESG - Warrants (09/09/2026)'s ROE evolved across reporting periods, while the comparison chart places FHLTW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.